Previous studies have suggested that tumor diameter and number are the most important factors that influence the effect of RFA, although primary lymph node status, timing of metastasis, and CEA levels can also influence patient survival and recurrence [30–33]. The gene discussed is CEACAM5; the disease is neoplasm.